ÉîÒ¹¸£Àû¹ú²ú¾«Æ·

Mike Waring

Explore more:

Popular searches

Donate Join us

Mike Waring

Newcastle University

Mike Waring

Biography

Mike Waring is Chair of Medicinal ÉîÒ¹¸£Àû¹ú²ú¾«Æ· at Newcastle University and Head of ÉîÒ¹¸£Àû¹ú²ú¾«Æ· for the Cancer Research UK Newcastle Drug Discovery Unit.  He was previously Principal Scientist in Medicinal ÉîÒ¹¸£Àû¹ú²ú¾«Æ· at AstraZeneca. He has worked mainly in the areas of diabetes and oncology and his work has contributed to the discovery of 14 drug candidates, including the marketed EGFR inhibitor osimertinib (Tagrissoâ„¢). 

He has made significant contributions to the field in many areas, perhaps most notably property-based optimisation, covalent inhibition, novel binding modes and new methods of hit generation.  He is a 2018 American Chemical Society Hero of ÉîÒ¹¸£Àû¹ú²ú¾«Æ· and recipient of the 2017 RSC Malcolm Campbell Medal.  He is an elected fellow of the Royal Society of ÉîÒ¹¸£Àû¹ú²ú¾«Æ·.

RSC affiliations

Contact Mike Waring

UK